A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development


l-type calcium channel (LTCC) antagonists have been used in bipolar disorder for over 30 years, without becoming an established therapeutic approach. Interest in this class of drugs has been rekindled by the discovery that LTCC genes are part of the genetic aetiology of bipolar disorder and related phenotypes. We have therefore conducted a systematic review… (More)
DOI: 10.1038/mp.2016.86


3 Figures and Tables


Citations per Year

Citation Velocity: 54

Averaging 54 citations per year over the last 2 years.

Learn more about how we calculate this metric in our FAQ.